Sunesis Pharmaceuticals to Report Financial Results for the First Quarter on May 8, 2008
April 30 2008 - 8:30AM
PR Newswire (US)
SOUTH SAN FRANCISCO, Calif., April 30 /PRNewswire-FirstCall/ --
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), a clinical-stage
biopharmaceutical company focused on the discovery, development and
commercialization of novel small-molecule therapeutics, today
announced that management will hold an investor conference call on
Thursday, May 8, 2008 at 11:00 a.m. ET/8:00 a.m. PT to discuss
financial results for the first quarter ended March 31, 2008.
Individual and institutional investors can access the call via
(877) 440-5786 (U.S. and Canada) or (719) 325-4929 (international).
To access the live audio webcast or the subsequent archived
recording, visit the "Investors and Media -- Calendar of Events"
section of the Sunesis website at http://www.sunesis.com/. Please
log on to Sunesis' website several minutes prior to the start of
the presentation to ensure adequate time for any software download
that may be necessary. About Sunesis Pharmaceuticals Sunesis is a
clinical-stage biopharmaceutical company focused on the discovery,
development and commercialization of novel small molecule
therapeutics for oncology and other serious diseases. Sunesis has
built a broad product candidate portfolio through internal
discovery and in-licensing of novel cancer therapeutics. Sunesis is
advancing its product candidates through in-house research and
development efforts and strategic collaborations with leading
pharmaceutical and biopharmaceutical companies. For additional
information on Sunesis Pharmaceuticals, please visit
http://www.sunesis.com/. DATASOURCE: Sunesis Pharmaceuticals, Inc.
CONTACT: Investors, Eric Bjerkholt, SVP, Corp. Development &
Finance of Sunesis Pharmaceuticals, Inc., +1-650-266-3717; or
Media, Karen L. Bergman, or Michelle Corral, both of BCC Partners,
+1-650-575-1509, or +1-415-794-8662, both for Sunesis
Pharmaceuticals, Inc. Web site: http://www.sunesis.com/
Copyright
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about Sunesis Pharmaceuticals Inc (NASDAQ): 0 recent articles
More Sunesis Pharmaceuticals (MM) News Articles